Author/Editor
Michael Robinson
Publisher
Money Map Press
Description
New high-end biotech service from Michael Robinson, who also edits the tech and biotech-focused Nexus-9 and Nova-X newsletters. Launched during the biotech boom caused by the COVID-19 pandemic, aims to produce a new recommendation every week, and focus on world-changing biotech innovations.
Newsletter is no longer active. Robinson left Money Map in July 2022.
Overall Rating
Rating: 4.4/5. From 5 votes.
Please wait...
4.0
Rating from 19 votes
If you’ve subscribed to Bio-Technology Profit Alliance (defunct), please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.
Investment Performance
Rating from 9 votes
Rating: 3.1/5. From 9 votes.
Please wait...
Your vote
- 5 Stars 1 Votes
- 4 Stars 3 Votes
- 3 Stars 3 Votes
- 2 Stars 0 Votes
- 1 Stars 2 Votes
Quality Of Writing/Analysis
Rating from 2 votes
Rating: 4.0/5. From 2 votes.
Please wait...
Your vote
- 5 Stars 1 Votes
- 4 Stars 0 Votes
- 3 Stars 1 Votes
- 2 Stars 0 Votes
- 1 Stars 0 Votes
Value For Price
Rating from 3 votes
Rating: 4.3/5. From 3 votes.
Please wait...
Your vote
- 5 Stars 2 Votes
- 4 Stars 0 Votes
- 3 Stars 1 Votes
- 2 Stars 0 Votes
- 1 Stars 0 Votes
Customer Service
Rating from 5 votes
Rating: 4.4/5. From 5 votes.
Please wait...
Your vote
- 5 Stars 2 Votes
- 4 Stars 3 Votes
- 3 Stars 0 Votes
- 2 Stars 0 Votes
- 1 Stars 0 Votes
Join joined 2 months ago and I have to say, I was expecting more hot leads in Bio-Tech Co’s.
Do you still have this subscirption